LightNews — News, ranked by scholars

@gmj-georgia.bsky.social

BREAKTHROUGH: New combination therapy achieves 83% complete remission in aggressive leukemia patients with FLT3 mutations. T…

#Bonemarrowtransplant #Cancertreatment #Combinationtherapy #FLT3mutations #Leukemia

#Bonemarrowtransplant #Cancertreatment #Combinationtherapy #FLT3mutations #Leukemia

…

New Drug Combo Hits 83% Leukemia Remission Rate

BREAKTHROUGH: New combination therapy achieves 83% complete remission in aggressive leukemia patients with FLT3 mutations. T… #Bonemarrowtransplant #Cancertreatment #Combinationtherapy #FLT3mutations #Leukemia

news.gmj.ge

May 26, 2026 at 4:37 PM

OncoDaily

@oncodaily.bsky.social

Does MARIPOSA study update simplify first-line treatment decisions? - Eric K. Singhi
@lungoncdoc.bsky.social
@mdanderson.bsky.social

oncodaily.com/insight/eric...

#Cancer #CombinationTherapy #MARIPOSAstudy #OncoDaily #Oncology #Osimertinib #Medicine #Health

Eric K. Singhi: Does MARIPOSA study update simplify first-line treatment decisions? - OncoDaily

Eric K. Singhi: Does MARIPOSA study update simplify first-line treatment decisions? / cancer, combination therapy, Eric K. Singhi, MARIPOSA study, MD Anderson

oncodaily.com

January 9, 2025 at 5:05 PM

Jen L, PhD

@drjkyl.bsky.social

Capivasertib/Fulvestrant in patients with HR+, HER2-low or HER2-negative locally advanced or metastatic breast cancer
@tamedoncol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#medicaloncology #combinationtherapy #targetedtherapy #oncosky #medsky #openaccess

August 8, 2025 at 4:45 PM

Jen L, PhD

@drjkyl.bsky.social

A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis

Therapeutic Advances in Hematology
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#leukemia #combinationtherapy #cancer #oncology #openaccess

April 3, 2026 at 4:15 PM

Diabetologia

@diabetologiajnl.bsky.social

Low-dose anti-CD3 + GLP1-E2 combination therapy synergised to delay & reduce T1D in NOD mice 🐁Immunomodulation + beta cell resilience = a potent path towards durable efficacy 🔬https://link.springer.com/article/10.1007/s00125-026-06750-1 🔓 #T1D #CombinationTherapy #aCD3 #GLP1-E2

May 29, 2026 at 11:01 AM

BioNews Central

@bionewscentral.com

A #GeneticallyEngineered #HerpesSimplexVirus, combined with #immunotherapy, reduces or eliminates #tumors in one-third of patients with #AdvancedMelanoma.
#Melanoma #OncolyticImmunotherapy #Nivolumab #CombinationTherapy

Cancer-fighting herpes virus combined with immunotherapy shown to be an effective treatment for some advanced melanoma – BioNews Central

A genetically engineered herpes simplex virus, combined with immunotherapy, reduces or eliminates tumors in one-third of patients with advanced melanoma. ...

sbee.link

July 9, 2025 at 10:05 PM

Jen L, PhD

@drjkyl.bsky.social

Clinical outcomes of treatments for patients with refractory metastatic colorectal cancer: a systematic literature review and network meta-analysis
@tamedoncol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#cancertreatment #combinationtherapy #oncology #openaccess

February 9, 2026 at 9:51 PM

Patrick Lennard 🦠🔬

@prlennard.bsky.social

💡 When assessing the combination of preventative SAAP-148 and post-infection halicin treatment in these cultures, I also found that SAAP-148 and halicin only acted synergistically in skin but not in lung tissue (still beneficial though!) #CombinationTherapy #SequentialTreatment

April 16, 2025 at 9:50 PM

The OncoAlert Network 🚨

@oncoalert.bsky.social

DAY Two of #CFS25 🚨
Dr. Vincent Xu breaks down the latest in combination therapy for Renal Cell Carcinoma (RCC). PD-1 based doublets are the standard of care for 1st-line metastatic disease. #KidneyCancer #RCC #CombinationTherapy

HCP's Register FOR FREE 👉 (USE CODE: ONCOALERT ) buff.ly/OWT0

November 13, 2025 at 2:55 PM

Monaghan Medical

@monaghanmedical.bsky.social

With the AEROECLIPSE® II BAN® Nebulizer and Aerobika® device in Combination Therapy, you can save time on treatments and spend more of it on what really matters – making memories together.
www.monaghanmed.com/product/comb...

#CombinationTherapy #TimeTogether #TeamMonaghan

November 26, 2024 at 4:24 PM

Cardiovascular Diseases Research Institute

@tumscvdri.bsky.social

#CombinationTherapy with SGLT-2 inhibitors and GLP-1 receptor agonists improves heart and #MetabolicOutcomes in type 2 #diabetes, reducing #HeartFailure #hospitalizations and major #CardiovascularEvents, with some increased GI side effects. #Diabetes dmsjournal.biomedcentral.com/articles/10....

Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of ran...

Background The potential benefits and risks of combination therapy with sodium-glucose co-transporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus monotherap...

dmsjournal.biomedcentral.com

July 21, 2025 at 6:11 AM

Glory Blaise Nweke

@esialb.bsky.social

Ceftazidime, a third-generation cephalosporin, showed reduced MIC from 32 μg/mL to 16 μg/mL when combined with hydroquinine against MDR P. aeruginosa. This multitarget approach enhances efficacy. What other combinations could lead to similar synergistic effects? #CombinationTherapy #Synergy

November 27, 2024 at 9:24 PM

healthdivine.bsky.social

@healthdivine.bsky.social

💊🧪 Combination Therapy Drug Market crossing $120.0B by 2032! Multi-drug regimens = better outcomes!
👉 #CombinationTherapy #PharmaTrends #HealthcareGrowth 💉📈

industrytoday.co.uk/health_and_s...

Combination Therapy Drug Market Forecasted to Surpass USD 120.0 Billion by 2032, Driven by a Strong 3.17% CAGR - Industry Today

Combination Therapy Drug Market Industry is expected to grow from 93.51(USD Billion) in 2024 to 120.0 (USD Billion) by 2032.

industrytoday.co.uk

August 4, 2025 at 12:16 PM

BioNews Central

@bionewscentral.com

Researchers have discovered a #SmallMolecule produced naturally by #GutBacteria that doubled the response to #LungCancer #immunotherapy in mice and can now be made into a #drug for testing in humans.
#LungCancerTreatment #CombinationTherapy #MicrobialMetabolite

Gut bacteria molecule boosts lung cancer immunotherapy – BioNews Central

Researchers have discovered a small compound produced naturally by gut bacteria that doubled the response to lung cancer immunotherapy in mice and can now be made into a drug for testing in humans. ...

sbee.link

January 15, 2026 at 7:45 PM

BioNews Central

@bionewscentral.com

A #CombinationTherapy of #trametinib and #rapamycin extends the #lifespan of mice by about 30 percent, improves their health in old age by reducing #ChronicInflammation, and delays the onset of #cancer.
#LifespanExtension #Healthspan

Combination therapy extends lifespan in mice – BioNews Central

A combination therapy of trametinib and rapamycin extends the lifespan of mice by about 30 percent, improves their health in old age by reducing chronic inflammation, and delays the onset of cancer. ...

sbee.link

May 30, 2025 at 5:24 PM

BioNews Central

@bionewscentral.com

Early-stage (phase 1/2) #ClinicalTrial shows that an #OralDrug combination for older #AcuteMyeloidLeukemia patients is an effective alternative to the standard intravenous treatment requiring frequent hospital visits.
#OlderAdults #AMLTreatment #CombinationTherapy

Oral drug combination eases treatment burden for acute myeloid leukemia patients – BioNews Central

Early-stage (phase 1/2) clinical trial shows that an all-oral drug combination for older acute myeloid leukemia patients is an effective alternative to the standard intravenous treatment requiring frequent hospital visits. ...

sbee.link

June 4, 2026 at 6:31 PM

BioNews Central

@bionewscentral.com

New research has identified a strategy to make #AntibodyDrugConjugates more effective against #metastatic #CastrationResistant #ProstateCancer, potentially overcoming #TreatmentResistance.
#ProstateCancerTreatment #CombinationTherapy

Combination of targeted therapies could help overcome treatment resistance in advanced prostate cancer – BioNews Central

New research has identified a strategy to make antibody-drug conjugates more effective against metastatic castration-resistant prostate cancer, potentially overcoming treatment resistance. ...

sbee.link

August 3, 2026 at 9:05 PM

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

#Haematology #Oncology #SMC #Columvi #glofitamab #combinationtherapy #secondline #lymphomatreatment #Scotland #Roche #ScottishMedicinesConsortium #NHSScotland #diffuselargeBcelllymphoma #autologousstemcelltransplant #LymphomaAction #Bcelllymphoma #STARGLOtrial
zurl.co/RJ6j0

SMC backs Columvi combination for second-line lymphoma treatment in Scotland - PharmaTimes

Roche therapy accepted for adults ineligible for stem cell transplant

pharmatimes.com

July 14, 2026 at 2:03 PM

GoggleDocs

@goggledocs.bsky.social

Finerenone: Do we need another treatment for #CKD in #T2D ❓

🔹 Reduces CKD progression by 23% & CV events by 14% (FIDELITY analysis).

🔸 Complements RASi & SGLT2i therapies, offering comprehensive cardio-renal protection.

❗️A new pillar in T2D & CKD Mx #CombinationTherapy.

🔗 ggdocs.co/nqip3c

January 21, 2025 at 3:00 PM

Infectious Diseases Now

@infdiseasesnow.bsky.social

4➡️Une communication courte étudiant le traitement de la bactériémie à S. aureus compliquée par bithérapie associant la pénicilline M ou la céfazoline à l'ertapénème.

www.sciencedirect.com/science/arti...

#IDSky #IDSkyFr #CombinationTherapy #Ertapenem #Oxacillin #Cefazolin #StaphylococcusAureus

May 1, 2026 at 11:28 AM

Infectious Diseases Now

@infdiseasesnow.bsky.social

[Publication] The article "Combination of #ertapenem and penicillin M or #cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: multicenter case series" is now available.

www.sciencedirect.com/science/arti...

#IDsky #CombinationTherapy #StaphylococcusAureus